Antipodes Partners LTD Alcon Inc Transaction History
Antipodes Partners LTD
- $3 Billion
- Q2 2025
A detailed history of Antipodes Partners LTD transactions in Alcon Inc stock. As of the latest transaction made, Antipodes Partners LTD holds 1,129,090 shares of ALC stock, worth $87.4 Million. This represents 3.32% of its overall portfolio holdings.
Number of Shares
1,129,090
Previous 1,195,712
5.57%
Holding current value
$87.4 Million
Previous $114 Million
12.19%
% of portfolio
3.32%
Previous 3.59%
Shares
4 transactions
Others Institutions Holding ALC
# of Institutions
774Shares Held
268MCall Options Held
11.9MPut Options Held
3.94M-
Vanguard Group Inc Valley Forge, PA20.9MShares$1.61 Billion0.03% of portfolio
-
Credit Suisse Ag Zurich, V815.5MShares$1.2 Billion1.27% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL11.7MShares$902 Million0.22% of portfolio
-
Norges Bank Oslo, Q811.3MShares$878 Million0.13% of portfolio
-
Aristotle Capital Management, LLC Los Angeles, CA11.1MShares$857 Million2.0% of portfolio
About ALCON INC
- Ticker ALC
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 490,087,008
- Market Cap $37.9B
- Description
- Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...